'Flanax' Ruling Driven By 'Ethical Outrage,' Drug Co. Says
A small drugmaker is urging the en banc Fourth Circuit to reconsider a recent ruling that Bayer AG could sue over a foreign trademark that it had never used in the...To view the full article, register now.
Already a subscriber? Click here to view full article